Recommendations and quality criteria for micronucleus studies with humans

Area of Science:

• Human genotoxicity assessment
• Biomarker research
• Clinical study methodology

Background:

• Micronucleus (MN) analysis in lymphocytes and exfoliated cells is a key method for detecting human genetic damage.
• MN formation results from exposure to genotoxins and nutritional deficiencies, correlating with cancer and non-cancer disease risks.
• MN measurements show potential for disease diagnosis, prognosis, and treatment monitoring, but clinical studies often have methodological flaws.

Purpose of the Study:

• To outline essential quality criteria for human micronucleus (MN) studies.
• To provide recommendations for acceptable study designs to improve data reliability.
• To address shortcomings in current clinical MN research.

Main Methods:

• Review of current micronucleus (MN) testing methodologies in human studies.
• Identification of critical parameters for robust study design, including sample size and duration.
• Emphasis on controlling confounding factors (e.g., sex, age, BMI, nutrition) and proper statistical analysis.

Main Results:

• Current human MN studies frequently suffer from methodological shortcomings, leading to inconsistent findings.
• Inadequate study designs limit the reliable assessment of genotoxic exposure, remediation strategies, disease diagnosis, and dietary impacts.
• Standardized quality criteria and improved study designs are necessary for valid MN analysis.

Conclusions:

• High-quality human micronucleus (MN) studies require attention to group sizes, study duration, confounding factors, cell scoring, staining, and statistical methods.
• Implementing recommended quality criteria will enhance the utility of MN analysis in toxicology, disease risk assessment, and clinical practice.
• Standardized, methodologically sound MN studies are vital for accurate biomarker interpretation and application.